News
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every ...
For the past several years, pharmaceutical giant Pfizer has been under investigation by the U.S. Department of Justice for ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
Three supercharged dividend stocks have the necessary catalysts to make their patient shareholders notably richer.
Pfizer exec Philip Dormitzer amid claims the COVID-19 vaccine announcement was delayed to avoid influencing the 2020 election ...
16h
Barchart on MSNHuge Unusual Volume in Pfizer Put Options Signals Investors Bullish OutlookLarge unusual trading volume in Pfizer, Inc. (PFE) put options that expire 30 days from now signals investors' bullish ...
We view Pfizer’s dividends and share repurchase levels as reasonable. Pfizer has generally targeted close to a 50% payout in dividends as a percentage of normalized earnings, which seems about right ...
Regeneron, playing catch up with J&J and Pfizer, wins FDA approval for Lynozyfic in multiple myeloma
Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
Shares of Pfizer Inc. PFE rose 1.12% to $25.32 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.47% to 6,227.42 and the Dow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results